scholarly article | Q13442814 |
editorial | Q871232 |
P50 | author | Jean-Claude Tardif | Q16244673 |
P2093 | author name string | François Roubille | |
P2860 | cites work | Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning | Q28187266 |
Myocardial reperfusion injury. | Q34687124 | ||
Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients | Q35654597 | ||
Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts | Q36763104 | ||
Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts | Q37277256 | ||
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. | Q37892456 | ||
Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes | Q43234743 | ||
Activated platelets contribute importantly to myocardial reperfusion injury | Q44914023 | ||
Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential. | Q46103192 | ||
Effect of cyclosporine on reperfusion injury in acute myocardial infarction | Q46453592 | ||
Postconditioning the human heart | Q46722557 | ||
Long-term benefit of postconditioning | Q46758924 | ||
Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury. | Q46891649 | ||
Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction | Q47305177 | ||
The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice. | Q51757699 | ||
Down-regulation of the transcription factor ZAC1 upon pre- and postconditioning protects against I/R injury in the mouse myocardium. | Q53203960 | ||
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary | Q56986933 | ||
P433 | issue | 2 | |
P304 | page(s) | 105-107 | |
P577 | publication date | 2013-04-01 | |
P1433 | published in | Cardiovascular Drugs and Therapy | Q2473050 |
P1476 | title | Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al. | |
P478 | volume | 27 |
Q51106338 | No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission. |
Q54296892 | Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade. |
Q38108537 | What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials |
Search more.